(d, JHH = 8.9 Hz, 1H, 4-Np), 7.54 (pseudo-d, JHH = 8.3 Hz, 2H,
o-Ph), 7.25 (ddd, JHH = 8.3 Hz, JHH = 6.8 Hz, JHH = 1.5 Hz, 1H,
7-Np), 7.201 (ddd, JHH = 8.1 Hz, JHH = 6.7 Hz, JPH = 1.4 Hz,
1H, 6-Np), 7.195 (pseudo-t, JHH = 8.1 Hz, 2H, m-Ph), 7.0 (tt,
JHH = 7.4 Hz, JHH = 1.0 Hz, 1H, p-Ph), 6.94 (d, JHH = 8.9 Hz,
1H, 3-Np), 3.58 (s, 3H, MeO), 2.08 (s, 3H, PCPhCMe), 1.70 (s,
3H, PCNpCMe), 1.62 (s, 15H, Cp*). 13C NMR (C6D6): d 154.6
(2-Np), 140.7 (d, J = 17.8 Hz, ipso-Ph), 134.7 (8a-Np), 130.4 (4a-
Np), 130.3 (d, J = 7.7 Hz, o-Ph), 128.9–127.8 (m-Ph, 4,5 and
8 Np), 126.0 (p-Ph), 126.0 (7-Np), 124.0 (6-Np), 123.4 (d, J =
12.8 Hz, 1-Np), 116.3 (3-Np), 102.4 (d, J = 59.5 Hz, PCPh), 97.9
(d, J = 61.5 Hz, PCNp), 93.5 (d, J = 3.9 Hz, PCCMe), 90.5 (d,
J = 2.7 Hz, PCCMe), 88.6 (Cp*), 58.5 (MeO), 16.8 (MeCCNp),
14.1 (MeCCPh), 10.9 (MeCp*). MS (CI{NH3} m/z, %) 580
([M]+, 45%), 190 (100%).
compound was obtained as deep orange crystals (50 mg, 19%).
Only one rotamer was visible in solution. 31P (C6D6): d −53.3.
1H (CDCl3): d 8.36 (d, JPH = 2.7 Hz, 1H), 7.68 (pseudo-t, JHH
=
8.1 Hz, 2H), 7.56 (pseudo-d, JHH = 8.1, 2H), 7.27–7.17 (m,
7H), 2.53 (s, 3H), 1.76 (s, 3H), 1.66 (s, 15H). 13C (CDCl3): d
149.8 (d, J = 1.6 Hz, 2-Np), 139.9 (d, J = 17 Hz, ipso-Ph),
133.9 (8a-Np), 129.2 (d, J = 11.6 Hz, o-Ph), 129.0 (CH), 128.8
(CH), 128.4 (CH), 128.0 (m-Ph), 126.1 (CH), 125.8 (CH), 125.3
(CH), 122.7 (CH), 117.0 (CH), 114.2 (d, J = 13.1 Hz, 1-Np),
98.5 (d, J = 56.8 Hz, PC), 96.5 (d, J = 3.9 Hz, PCC), 91.4 (d,
J = 55.6 Hz, PC), 91.1 (d, J = 3.7 Hz, PCC), 83.7 (Cp*), 14.9
(MeCCP); 14.2 (MeCCP), 10.1 (Me from Cp*). EI-MS (m/z,
%) 521 ([M]+, 100%)
trans-Dichloro(triethylphosphine)[g5-pentamethylcyclopenta-
dienyl{g5-2-(2ꢀ-methoxynaphth-1ꢀ-yl)-3,4-dimethyl-5-phenyl-
phospholyl}ruthenium(II)]platinum(II) 9 and 10
g5-Pentamethylcyclopentadienyl{g5-2-(2ꢀ-methoxynaphth-1ꢀ-
yl)-3,4-dimethyl-5-phenylphospholyl}iron(II) 6
A THF (50 mL) solution of 4 (4.7 mmol) was added to a THF
(40 mL) solution of freshly prepared ‘[Cp*FeCl]n’ (4.7 mmol),
causing a colour change from bright green to orange. After
checking completion of the reaction by 31P NMR, the solvent
was evaporated in vacuo and the residue was taken up in
toluene (100 mL). After filtration through a pad of Celite, the
orange solution was concentrated to ca. 20 mL and layered with
degassed methanol (50 mL) to give an orange solution. Orange
crystalline 6 was obtained upon standing (1.5 g, 60%). Solution
rotamer ratio: 1 (6b) : 0.42 (6a) in C6D6 at 298 K. Major (6b):
Finely divided [PtCl2(PEt3)]2 (6.6 mg, 8.6 lmol) was added
to a C6D6 (0.4 mL) solution of 5 (10 mg, 0,017 mmol) at
room temperature. The sample was shaken vigorously and the
composition of the yellow solution was investigated in situ by
NMR spectroscopy. A ratio of 0.58 (9) : 1 (10) was observed in
C6D6 at 298 K. 10 (Major): 31P NMR (CDCl3): d 20.52 (JP–Pt
=
2637 Hz, JP–P = 562 Hz); 14.49 (JP–Pt = 2955 Hz, JP–P = 562 Hz).
1H NMR (C6D6): d 9.96 (d, JHH = 8.5 Hz, 1H, 8-Np), 7.85 (ddd,
JHH = 8.2 Hz, JHH = 6.8 Hz, JHH = 1.3 Hz, 1H, 7-Np), 7.73 (d,
JHH = 8.3 Hz, 1H, 5-Np), 7.72 (pseudo-d, JHH = 7.9 Hz, 2H, o-
Ph), 7.60 (d, JHH = 9.0 Hz, 1H, 4-Np), 7.40 (ddd, JHH = 7.4 Hz,
1
31P (C6D6): d −36.4. H NMR (C6D6): d 7.71 (m, 1H, 8-Np),
7.70 (pseudo-d, JHH = 7.7 Hz, 1H, 5-Np), 7.65 (pseudo-t, JHH
=
JHH = 6.9 Hz, JPH = 1.0 Hz, 1H, 6-Np), 7.22 (pseudo-t, JHH =
7.7 Hz, 1H, 7-Np), 7.64 (pseudo-d, JHH = 7.1 Hz, 2H, o-Ph),
7.57 (d, JHH = 9.0 Hz, 1H, 4-Np), 7.36 (ddd, JHH = 7.9 Hz,
7.9 Hz, 2H, m-Ph), 7.04 (pseudo-t, JHH = 7.9 Hz, 1H, p-Ph),
7.02 (d, JHH = 9.0 Hz, 1H, 3-Np), 3.65 (s, 3H, MeO), 2.05 (s, 3H,
MeCCP), 2.04 (s, 3H, MeCCP), 1.71 (s, 15H, Cp*), 1.43 (m, 6H,
CH2), 0.7 (m, 9H, CH3). 9 (Minor): 31P NMR (CDCl3): d 25.9
JHH = 6.9 Hz, JPH = 1.1 Hz, 1H, 6-Np), 7.16 (pseudo-t, JHH
=
7.1 Hz, 2H, m-Ph), 7.06 (pseudo-t, JHH = 7.1 Hz, 1H, p-Ph),
6.93 (d, JHH = 9.0 Hz, 1H, 3-Np), 3.62 (s, 3H, MeO), 2.30 (s, 3H,
MeCCP), 1.86 (s, 3H, MeCCP), 1.57 (s, 15H, Cp*). 13C NMR
(C6D6): d 154.2 (2-Np), 141.6 (d, J = 16.9 Hz, ipso-Ph), 135.2
(d, J = 3.4 Hz, 8a-Np), 130.5 (4a-Np), 130.3 (d, J = 11.4 Hz,
o-Ph), 128.9–128.0 (m-Ph, 4-, 5- and 8-Np), 125.9 (p-Ph), 125.8
(7-Np), 123.9 (6-Np), 123.4 (d, J = 13.6 Hz, 1-Np), 115.7 (3-
Np), 98.8 (d, J = 56.9 Hz, PCPh), 96.2 (d, J = 58.7 Hz, PCNp),
93.5 (d, J = 4.9 Hz, PCCMe), 89.3 (d, J = 4.2 Hz, PCCMe),
83.3 (Cp*), 57.8 (MeO), 17.5 (MeCCP), 14.9 (MeCCP), 10.8
(MeCp*). Minor (6a): 31P (C6D6): d −42.8. 1H NMR (C6D6): d
10.1 (d, JHH = 8.5 Hz, 1H, 8-Np), 7.74 (pseudo-d, JHH = 7.5 Hz,
2H, o-Ph), 7.73 (m, 1H, 5-Np), 7.70 (m, 1H, 8-Np), 7.67 (m, 1H,
(JP–Pt = 2689 Hz, JP–P = 572 Hz), 13.24 (JP–Pt = 2931 Hz, JP–P
=
572 Hz). 1H NMR (C6D6): d 8.14 (d, JHH = 7.3 Hz, 1H, 8-Np),
8.10 (pseudo-d, JHH = 8.0 Hz, 2H, o-Ph), 7.60 (d, JHH = 8.0 Hz,
1H, 5-Np), 7.54 (d, JHH = 8.9 Hz, 1H, 4-Np), 7.32 (pseudo-t,
JHH = 7.9 Hz, 2H, m-Ph), 7.29 (pseudo-t, JHH = 7.5 Hz, 1H,
7-Np), 7.16 (pseudo-t, JHH = 8 Hz, 1H, 6-Np), 7.14 (pseudo-t,
JHH = 7.9 Hz, 1H, p-Ph), 7.05 (d, JHH = 8.9 Hz, 1H, 3-Np), 4.26
(s, 3H, MeO), 2.04 (s, 3H, MeCCP), 1.91 (s, 3H, MeCCP), 1.74
(s, 15H, Cp*), 1.25 (m, 6H, CH2), 0.6 (m, 9H, CH3).
cis-Dichloro(triethylphosphine)-g5-[pentamethylcyclopentadienyl-
g5-{2-(2ꢀ-methoxynaphth-1ꢀ-yl)-3,4-dimethyl-5-
7-Np), 7.55 (d, JHH = 8.8 Hz, 1H, 4-Np), 7.21 (pseudo-t, JHH
=
7.5 Hz, 2H, m-Ph), 7.16 (m, 1H, 6-Np), 7.10 (pseudo-t, JHH
=
phenylphospholyl}ruthenium(II)]platinum(II) 11 and 12
7.5 Hz, 1H, p-Ph), 6.95 (d, JHH = 8.8 Hz, 1H, 3-Np), 3.21 (s, 3H,
MeO), 2.35 (s, 3H, MeCCP), 2.17 (s, 3H, MeCCP), 1.51 (s, 15H,
Cp*). 13C NMR (C6D6): d 156.3 (d, J = 2.5 Hz, 2-Np), 141.2
(d, J = 17.2 Hz, ipso-Ph), 132.8 (8a-Np), 130.4 (4a-Np), 130.1
(d, J = 11.6 Hz, o-Ph), 128.9–128.0 (m-Ph, 4-, 5- and 8-Np),
125.8 (p-Ph), 125.1 (7-Np), 124.3 (6-Np), 123.4 (d, J = 13.6 Hz,
1-Np), 117.7 (3-Np), 98.6 (d, J = 56.1 Hz, PCPh), 96.1 (d, J =
4.5 Hz, PCCMe), 95.9 (d, J = 57.2 Hz, PCNp), 89.7 (d, J =
3.6 Hz, PCCMe), 83.9 (Cp*), 56.5 (MeO), 15.8 (MeCCNp), 15.2
(MeCCPh), 11.0 (MeCp*). EI-MS (m/z, %) 534 ([M]+, 100%).
Finely divided [PtCl2(PEt3)]2 (6.6 mg, 8.6 lmol) was added to
a CDCl3 (0.4 mL) solution of 5 (10 mg, 0,017 mmol) and the
initially formed mixture of 9 and 10 was allowed to stand at room
temperature for 15 days, whereupon the combined conversion
into the cis isomers 11 and 12 had reached 78%. Diffusion of
methanol into the solution afforded pure colourless crystals of
12 suitable for X-ray analysis. Redissolution of the crystals gave
only one cis-isomer whose spectrum was identical to the major
isomer originally present in the mixture. 12: 31P NMR(CDCl3):
d 21.82 (JP–Pt = 4552 Hz, JP–P = 24.5 Hz), 12.99 (JP–Pt = 3184 Hz,
1
JP–P = 24.5 Hz). H NMR (CDCl3): d 9.49 (d, JHH = 8.5 Hz,
g5-Pentamethylcyclopentadienyl[g5-2-(2ꢀ-hydroxynaphth-1ꢀ-
yl)-3,4-dimethyl-5-phenylphospholyl}iron(II) 8
1H, 8-Np), 7.79 (d, JHH = 8.8 Hz, 1H, 4-Np), 7.76 (ddd, JHH
7.7 Hz, JHH = 7.7 Hz, JHH = 1.3 Hz, 1H, 7-Np), 7.70 (d, JHH
=
=
A THF (5 mL) solution containing 4 and dipotassium{2-
(2ꢀ-oxynaphth-1ꢀ-yl)-3,4-dimethyl-5-phenylphospholide (d31P
(THF): 76 ppm) (0.5 mmol) was added to a THF (5 mL)
solution of freshly prepared [FeCp*(acac)] (0.5 mmol). The
solvents were evaporated in vacuo and the residue was extracted
into toluene and passed through a pad of silica. The orange
filtrate was evaporated to dryness under reduced pressure
and recrystallised from dichloromethane/methanol. The title
7.5 Hz, 1H, 5-Np), 7.59 (d, JHH = 7.5 Hz, 1H, o-Ph), 7.38 (ddd,
JHH = 7.7 Hz, JHH = 7.7 Hz, JHH = 1.1 Hz, 1H, 6-Np), 7.30
(pseudo-t, JHH = 7.6 Hz, 2H, m-Ph), 7.17 (d, JHH = 8.5 Hz, 1H,
3-Np), 7.15 (pseudo-t, JHH = 7.6 Hz, 1H, p-Ph), 3.93 (s, 3H,
MeO), 2.26 (s, 3H, MeCCP), 1.97 (s, 3H, MeCCP), 1.82 (s, 15H,
Me-Cp*), 1.55 (m, 6H, CH2), 0.19 (m, 9H, CH3). 11: 31P NMR
(CDCl3): d 26.0 (JP–Pt = 4665 Hz, JP–P = 22.4 Hz), 13.1 (JP–Pt
=
3199 Hz, JP–P = 22.4 Hz).
D a l t o n T r a n s . , 2 0 0 5 , 2 1 7 3 – 2 1 8 1
2 1 7 9